Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum IV Iron to Treat Iron Deficiency Anemia Post Delivery Trial
PACTR202307876581314Phase 4Not yet recruiting
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Aug 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in iron deficiency anemia (IDA) comparing Intravenous iron with Oral iron and folate (2 arms). Primary endpoint: Maternal non-anemic state. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
Ironfolate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on PACTR202307876581314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202307876581314.